A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 51
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : 6-keto PGF1 alpha
Long Form : 6-keto prostaglandin F1 alpha
No. Year Title Co-occurring Abbreviation
2018 Investigation of the therapy targets of Yi-Qi-Yang-Yin-Hua-Tan-Qu-Yu recipe on type 2 diabetes by serum proteome labeled with iTRAQ. cAMP, CDC42, cGMP, ET-1, HDL-C, HFD, LDL-C, RhoA, TC, TG, TXB2, YQYYHTQY
2017 Reduced platelet aggregation in women after intercourse: a possible role for the cyclooxygenase pathway. AA, ADP, PGE-M, SF
2014 Nano-LC-MS/MS for the quantitation of prostanoids in immune cells. FDA, LLOQ, PGD2, PGE2, PGF2 alpha, TXB2
2004 Ozone exposure induces iNOS expression and tyrosine nitration in rat aorta. iNOS
2002 Differential regulation of prostacyclin and thromboxane by dexamethasone and celecoxib during oxidative stress in newborn rabbits. 8-epi-PGF2alpha, CEL, DEX, RA, TXA2
2001 Serotonin 5-HT1 receptors potentiate histamine and thrombin stimulated prostaglandin synthesis in endothelial cells. 5-CT, HAEC, PGF2 alpha
2000 Differential effects of nitric oxide on the activity of prostaglandin endoperoxide H synthase-1 and -2 in vascular endothelial cells. cGMP, LPS, NO, PGHS
2000 Moderate hypothermia improves imbalances of thromboxane A2 and prostaglandin I2 production after traumatic brain injury in humans. TBI, TXB2
2000 [Differential action of non-steroidal antiinflammatory drugs on human gallbladder cyclooxygenase and lipoxygenase]. 5-HETE, COX I, INDO, LC, NSAID, PGE2, PGF2 alpha, PGs
10  1999 Estrogen decreases prostaglandin H synthase products from endothelial cells. NO, PGHS, TXB2
11  1999 Plasma levels of nitric oxide and related vasoactive factors following long-term treatment with angiotensin-converting enzyme inhibitor in patients with essential hypertension. ACE, Ang II, cGMP, NO
12  1999 Protective effect of tyrphostin AG-556 on shock induced by endotoxin or gram positive bacteria. COX-2, GBS, LPS, TXB2, TYR
13  1998 Effect of gemfibrozil on serum levels of prostacyclin and precursor fatty acids in hyperlipidemic patients with Type 2 diabetes. ---
14  1998 Excessive vasoconstriction after stress by the aging kidney: inadequate prostaglandin modulation of increased endothelin activity. ERPF, ET-1, FF, GFR, MS, PGE2
15  1996 Leukotriene synthesis inhibition and anti-ige challenge of human lung parenchyma. LT
16  1996 Rapid quantitation of a large scope of eicosanoids in two models of inflammation: development of an electrospray and tandem mass spectrometry method and application to biological studies. LPS, MS/MS, PGE2, TXB2
17  1995 Diurnal rhythm of prostanoid secretion from bone/marrow organ in the rat. PGE2, PGF2 alpha, RIA, TXB2
18  1995 Effects of cyclosporin A and dexamethasone on haemostatic and vasoactive functions of vascular endothelial cells. CsA, DX, HUVEC, PAI-1, tPA, TSP, vWF
19  1995 Ganglioside GM1 prevents N-methyl-D-aspartate neurotoxicity in rabbit hippocampus in vivo. Effects on calcium homeostasis. NMDA
20  1995 N-methyl-D-aspartate-evoked release of cyclo-oxygenase products in rabbit hippocampus: an in vivo microdialysis study. NMDA, TXB2
21  1994 Essential fatty acid deficiency in the pig: effects on eicosanoid basal levels and in vitro synthesis by the small intestine. COX, EFA, LTB4, PLA2, TXB2
22  1994 Prostanoid production in hypoxic rat isolated atria: influence of acute diabetes. TXB2
23  1993 Cyclooxygenase and lipoxygenase metabolism in sodium taurocholate induced acute hemorrhagic pancreatitis in rats. AP, LTB4, PGE2, TXB2
24  1993 Decreased 6-keto prostaglandin F1 alpha (6-keto PGF1 alpha) in patients with Lesch-Nyhan syndrome. LNS
25  1993 Effect of prostaglandins on renal function in uninephrectomized humans. ERPF, GFR, PGE2, UN
26  1993 Modulating effect of amount and types of dietary fat on ornithine decarboxylase, tyrosine protein kinase and prostaglandins production during colon carcinogenesis in male F344 rats. AOM, ODC, PGE2, TPK
27  1993 Profile of prostaglandins induced by endothelin-1 in human brain capillary endothelium. ET-1, PGD2, PGE2, PGF2 alpha, PLA2, PLC, TXB2
28  1992 Pancreas prostanoid production in ischemia and reperfusion. TXB2
29  1991 Concentration-dependent effects of protein kinase C-activating and -nonactivating phorbol esters on myocardial contractility, coronary resistance, energy metabolism, prostacyclin synthesis, and ultrastructure in isolated rat hearts. Effects of amiloride. PDBu, PMA
30  1991 Prostanoid production and pulmonary hypertension after fat embolism are not modified by methylprednisolone. BCA, MPSS, PAP, PVR, TXB2
31  1991 Sequential release of tumour necrosis factor, platelet activating factor and eicosanoids during endotoxin shock in anaesthetized pigs: protective effects of indomethacin. LPS, LTB4, MABP, PAF, TNF, TXB2
32  1991 Tissular prostanoid release, phospholipase A2 activity, and lipid peroxidation in pancreas transplantation. OFR, PLA2, TXB2
33  1990 Calcium-ionophore A23187 induces dual changes in the release of 5-lipoxygenase and cyclooxygenase products by macrophages. LTB4, TXB2
34  1990 The role of prostanoids in the production of acute acalculous cholecystitis by platelet-activating factor. PAF, PGE
35  1989 Differential control and calcium-dependence of production of endothelium-derived relaxing factor and prostacyclin by pig aortic endothelial cells. EDRF
36  1989 Methylene blue but not changes in cyclic GMP inhibits resting and bradykinin-stimulated production of prostacyclin by pig aortic endothelial cells. ---
37  1989 [Alteration of prostaglandin metabolism in alcoholic liver disease: its association with platelet dysfunction after chronic alcohol ingestion]. ALD, TXB2
38  1988 The effect of nifedipine and captopril on platelet activation and prostanoid production in essential hypertension. ---
39  1987 6-keto prostaglandin F1 alpha and thromboxane B2 in isolated, buffer-perfused lungs from monocrotaline pyrrole-treated rats. MCTP, TXB2
40  1987 Effect of single-dose aspirin on TXA2 and PGI2 cyclooxygenases in vivo. AA, TXA2, TXB2
41  1987 Prostaglandin associated mortality following intravenous injection of catfish epidermal secretions in rabbits. TXB2
42  1986 Effect of non-steroidal anti-inflammatory drugs on control of hypertension by beta-blockers and diuretics. NSAIDs
43  1986 Exudative, cellular and humoral reactions to platelet-activating factor (PAF-acether) in the pleural cavity of rats. TXB2
44  1985 Response of Walker 256 carcinosarcoma cells to 12-O-tetradecanoylphorbol 13-acetate: possible regulation by endogenous cyclooxygenase metabolites. PGE2
45  1984 6-Keto prostaglandin F1 alpha, thromboxane B2 and 13,14-dihydro-15-keto prostaglandin F levels in maternal and fetal plasma. TXB2
46  1984 Leukotriene-induced contraction and thromboxane production in guinea-pig lung parenchymal strips. LTs, TXA2, TXB2
47  1984 Pathophysiological mechanisms of sudden death induced by platelet activating factor. MABP, PAF, TXB2
48  1983 Formation of 6-keto prostaglandin E1 in mammalian kidneys. ---
49  1982 A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2. PGE2
50  1982 Stimulation of prostacyclin production from vascular endothelial cells by plasma, serum and platelets under normal and pathological conditions. SLE, SS
51  1981 Plasma 6 keto PGE1 alpha concentration in Raynaud's phenomenon. PSS, TXB2